FibroBiologics, Inc. Common Stock (FBLG) vs iSpecimen Inc. (ISPC)
A side-by-side comparison of FibroBiologics, Inc. Common Stock and iSpecimen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FBLG
FibroBiologics, Inc. Common Stock
$1.21HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT
ISPC
iSpecimen Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 11:23 AM EDT
Total return — FBLG vs ISPC
growth of $100 · dividends reinvested · last 3yFBLG -99.8% (-87.3%/yr)ISPC -99.7% (-85.8%/yr)ISPC compounded faster over this window
FBLG ISPC
FBLG vs ISPC: by the numbers
- •ISPC is the larger company ($3M vs $3M market cap).
- •Both run net losses; FBLG's is the smaller (0.00% vs -2449.04% net margin).
Metrics side by side
Valuation
| Metric | FBLG | ISPC |
|---|---|---|
| P/S ratio | N/A | 5.73 |
| P/B ratio | 0.54 | 1.54 |
Profitability
| Metric | FBLG | ISPC |
|---|---|---|
| Gross margin | 0.00% | 1.25% |
| Operating margin | 0.00% | -465.42% |
| Net margin | 0.00% | -2449.04% |
| ROE | -391.26% | -657.69% |
| ROIC | -286.46% | -476.39% |
Growth (annualized)
| Metric | FBLG | ISPC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -46.70% |
| Total return CAGR (5Y) | N/A | -81.14% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.